ProKidney Corp. (PROK)
1.75
0.00 (0.00%)
USD |
NASDAQ |
May 22, 16:00
1.745
0.00 (0.00%)
After-Hours: 20:00
ProKidney EPS Diluted (Quarterly) : -0.1412 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | -0.1646 |
| Karyopharm Therapeutics, Inc. | -1.236 |
| Rocket Pharmaceuticals, Inc. | -0.4244 |
| ARS Pharmaceuticals, Inc. | -0.6105 |
| Korro Bio, Inc. | -1.692 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -42.62M |
| Revenue (Quarterly) | 0.226M |
| Total Expenses (Quarterly) | 20.26M |
| Enterprise Value | 1.425B |
| Gross Profit Margin (Quarterly) | -535.0% |
| Profit Margin (Quarterly) | -18.86K% |
| Earnings Yield | -30.10% |
| Normalized Earnings Yield | -30.10 |